{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:32:45Z","timestamp":1780525965900,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["No. 2024ZD0527000 and No. 2024ZD0527002"],"award-info":[{"award-number":["No. 2024ZD0527000 and No. 2024ZD0527002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Kawasaki disease (KD) remains the leading cause of acquired heart disease in children. While intravenous immunoglobulin (IVIG) represents standard therapy, approximately 10\u201320% of patients exhibit treatment refractoriness associated with significantly elevated coronary artery lesion risk. Current risk stratification relies on clinical parameters\u2014fever duration or nonspecific inflammatory markers\u2014which fail to capture distinct immunopathological features associated with treatment failure. To bridge this gap, we employed a convergent strategy integrating transcriptomic discovery from two independent cohorts with prospective protein-level and cellular validation in a clinical cohort. Three machine learning models\u2014LASSO regression, Random Forest, and XGBoost\u2014independently identified TREM1 (Triggering Receptor Expressed on Myeloid cells-1) as a core resistance predictor. Prospective validation in 117 KD patients demonstrated that plasma soluble TREM-1 (sTREM-1) was markedly elevated in IVIG-resistant cases (median 1247 vs. 856 pg\/mL,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.001) and effectively differentiated KD from other febrile illnesses. Mechanistically, sTREM-1 elevation showed a moderate positive correlation with myeloperoxidase-DNA complexes (\u03c1\u2009=\u20090.612,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.001), indicating that TREM-1-associated neutrophil hyperactivation is associated with excessive neutrophil extracellular trap (NET) formation and vascular injury. External validation (GSE63881) confirmed TREM1 upregulation (2.1-fold) in resistant patients. Incorporating sTREM-1 into a multivariable prediction model achieved area under curve 0.884 using Firth\u2019s penalized logistic regression (optimism-corrected AUC 0.871) in this derivation cohort, significantly outperforming traditional clinical scores. These findings suggest TREM-1-associated NETosis as a potential contributor to the pathobiology of IVIG resistance. As a TRIPOD Type 1b derivation study, external clinical validation in independent multi-center cohorts is required prior to clinical implementation.\n                  <\/jats:p>","DOI":"10.1007\/s10875-026-02025-x","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T22:56:07Z","timestamp":1776725767000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["TREM-1-Associated Neutrophil Extracellular Trap Formation is Linked to IVIG Resistance in Kawasaki Disease: A Convergent Transcriptomic and Prospective Validation Study"],"prefix":"10.1007","volume":"46","author":[{"given":"Sibao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixian","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"issue":"17","key":"2025_CR1","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","volume":"135","author":"BW McCrindle","year":"2017","unstructured":"McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):e927\u201399.","journal-title":"Circulation"},{"issue":"2","key":"2025_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1136\/heartjnl-2012-302126","volume":"99","author":"S Chen","year":"2013","unstructured":"Chen S, Dong Y, Yin Y, Krucoff MW. Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis. Heart. 2013;99(2):76\u201382.","journal-title":"Heart"},{"issue":"22","key":"2025_CR3","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.105.592865","volume":"113","author":"T Kobayashi","year":"2006","unstructured":"Kobayashi T, Inoue Y, Takeuchi K, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation. 2006;113(22):2606\u201312.","journal-title":"Circulation"},{"issue":"5","key":"2025_CR4","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jpeds.2010.10.031","volume":"158","author":"LA Sleeper","year":"2011","unstructured":"Sleeper LA, Minich LL, McCrindle BM, et al. Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J Pediatr. 2011;158(5):831-e8353.","journal-title":"J Pediatr"},{"issue":"8","key":"2025_CR5","first-page":"583","volume":"149","author":"P Vega-Fernandez","year":"2024","unstructured":"Vega-Fernandez P, Yamamoto K, Nelson-Maney N, et al. Single-cell meta-analysis of neutrophil activation in Kawasaki disease and multisystem inflammatory syndrome in children reveals potential shared immunological drivers. Circulation. 2024;149(8):583\u201397.","journal-title":"Circulation"},{"issue":"2","key":"2025_CR6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nri.2017.105","volume":"18","author":"V Papayannopoulos","year":"2018","unstructured":"Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol. 2018;18(2):134\u201347.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"2025_CR7","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/s41390-019-0710-3","volume":"87","author":"Y Yoshida","year":"2020","unstructured":"Yoshida Y, Takeshita S, Kawamura Y, Kanai T, Tsujita Y, Nonoyama S. Enhanced formation of neutrophil extracellular traps in Kawasaki disease. Pediatr Res. 2020;87(6):998\u20131004.","journal-title":"Pediatr Res"},{"issue":"8","key":"2025_CR8","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1161\/ATVBAHA.118.311150","volume":"38","author":"EJ Folco","year":"2018","unstructured":"Folco EJ, Mawson TL, Vromman A, et al. Neutrophil extracellular traps induce endothelial cell activation and tissue factor production through interleukin-1\u03b1 and cathepsin G. Arterioscler Thromb Vasc Biol. 2018;38(8):1901\u201312.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"2025_CR9","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1161\/ATVBAHA.117.309897","volume":"38","author":"AK Meher","year":"2018","unstructured":"Meher AK, Spinosa M, Davis JP, et al. Novel role of IL (interleukin)-1\u03b2 in neutrophil extracellular trap formation and abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 2018;38(4):843\u201353.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"2025_CR10","doi-asserted-by":"publisher","first-page":"e182293","DOI":"10.1001\/jamapediatrics.2018.2293","volume":"172","author":"VJ Wright","year":"2018","unstructured":"Wright VJ, Herberg JA, Kaforou M, et al. Diagnosis of Kawasaki disease using a minimal whole-blood gene expression signature. JAMA Pediatr. 2018;172(10):e182293.","journal-title":"JAMA Pediatr"},{"issue":"9","key":"2025_CR11","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.humimm.2010.06.008","volume":"71","author":"W Fury","year":"2010","unstructured":"Fury W, Tremoulet AH, Watson VE, et al. Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistance. Hum Immunol. 2010;71(9):865\u201373.","journal-title":"Hum Immunol"},{"issue":"11","key":"2025_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-014-0102-6","volume":"6","author":"LT Hoang","year":"2014","unstructured":"Hoang LT, Shimizu C, Ling L, et al. Global gene expression profiling identifies new therapeutic targets in acute Kawasaki disease. Genome Med. 2014;6(11):541.","journal-title":"Genome Med"},{"issue":"2","key":"2025_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","volume":"4","author":"RA Irizarry","year":"2003","unstructured":"Irizarry RA, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4(2):249\u201364.","journal-title":"Biostatistics"},{"issue":"6","key":"2025_CR14","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012;28(6):882\u20133.","journal-title":"Bioinformatics"},{"issue":"7","key":"2025_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2025_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1\u201322.","journal-title":"J Stat Softw"},{"issue":"1","key":"2025_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L. Random forests. Mach Learn. 2001;45(1):5\u201332.","journal-title":"Mach Learn"},{"key":"2025_CR18","doi-asserted-by":"crossref","unstructured":"Chen T, Guestrin C, XGBoost. A scalable tree boosting system. Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. 2016:785\u2013794.","DOI":"10.1145\/2939672.2939785"},{"issue":"1","key":"2025_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/biomet\/80.1.27","volume":"80","author":"D Firth","year":"1993","unstructured":"Firth D. Bias reduction of maximum likelihood estimates. Biometrika. 1993;80(1):27\u201338.","journal-title":"Biometrika"},{"key":"2025_CR20","doi-asserted-by":"publisher","unstructured":"Puhr R, Heinze G, Nold M, Lusa L, Geroldinger A. Firth\u2019s logistic regression with rare events: accurate effect estimates and predictions? Stat Med. 2017;36(14):2302\u201317. https:\/\/doi.org\/10.1002\/sim.7273","DOI":"10.1002\/sim.7273"},{"key":"2025_CR21","doi-asserted-by":"crossref","unstructured":"Harrell F Jr, Lee L, Mark B. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4):361\u201387.","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4"},{"issue":"3","key":"2025_CR22","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837\u201345.","journal-title":"Biometrics"},{"key":"2025_CR23","doi-asserted-by":"crossref","unstructured":"Pencina J, D\u2019Agostino R Sr, D\u2019Agostino R Jr, Vasan S. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157\u201372.","DOI":"10.1002\/sim.2929"},{"issue":"6","key":"2025_CR24","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","volume":"26","author":"AJ Vickers","year":"2006","unstructured":"Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Mak. 2006;26(6):565\u201374.","journal-title":"Med Decis Mak"},{"issue":"1","key":"2025_CR25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.coi.2009.01.009","volume":"21","author":"JW Ford","year":"2009","unstructured":"Ford JW, McVicar DW. TREM and TREM-like receptors in inflammation and disease. Curr Opin Immunol. 2009;21(1):38\u201346.","journal-title":"Curr Opin Immunol"},{"issue":"6","key":"2025_CR26","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nri1106","volume":"3","author":"M Colonna","year":"2003","unstructured":"Colonna M. TREMs in the immune system and beyond. Nat Rev Immunol. 2003;3(6):445\u201353.","journal-title":"Nat Rev Immunol"},{"issue":"21","key":"2025_CR27","doi-asserted-by":"publisher","first-page":"9813","DOI":"10.1073\/pnas.0909927107","volume":"107","author":"A Hakkim","year":"2010","unstructured":"Hakkim A, F\u00fcrnrohr BG, Amann K, et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci U S A. 2010;107(21):9813\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2025_CR28","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.autrev.2009.12.004","volume":"9","author":"C Galeotti","year":"2010","unstructured":"Galeotti C, Bayry J, Kone-Paut I, Kaveri SV. Kawasaki disease: aetiopathogenesis and therapeutic utility of intravenous immunoglobulin. Autoimmun Rev. 2010;9(6):441\u20138.","journal-title":"Autoimmun Rev"},{"issue":"9930","key":"2025_CR29","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/S0140-6736(13)62298-9","volume":"383","author":"AH Tremoulet","year":"2014","unstructured":"Tremoulet AH, Jain S, Jaggi P, et al. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial. Lancet. 2014;383(9930):1731\u20138.","journal-title":"Lancet"},{"issue":"14","key":"2025_CR30","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1001\/jama.292.14.1759","volume":"292","author":"S Gibot","year":"2004","unstructured":"Gibot S, Cravoisy A, Kolopp-Sarda MN, et al. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. JAMA. 2004;292(14):1759\u201366.","journal-title":"JAMA"},{"key":"2025_CR31","doi-asserted-by":"publisher","DOI":"10.1177\/08977151251392582","author":"L Huang","year":"2025","unstructured":"Huang L, Zhang S, Wang C, Wang F. The protective effects of the triggering receptor expressed on myeloid cells-1 inhibitor LP17 on experimental acute brain injury: a systematic review and meta-analysis based on animal models. J Neurotrauma. 2025. https:\/\/doi.org\/10.1177\/08977151251392582.","journal-title":"J Neurotrauma"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-026-02025-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-026-02025-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-026-02025-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:15:04Z","timestamp":1780391704000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-026-02025-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2025"],"URL":"https:\/\/doi.org\/10.1007\/s10875-026-02025-x","relation":{},"ISSN":["1573-2592"],"issn-type":[{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"14 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received approval from the Institutional Ethics Committee of Women and Children\u2019s Hospital, Qingdao University (Reference: QDFYKY-2021-12) prior to enrollment of any participants, covering both biospecimen collection and clinical data extraction. Written informed consent was secured from the legal guardians of all participating children, clearly delineating the study\u2019s objectives, blood sampling protocols, associated risks, data confidentiality safeguards, and the right to withdraw without compromising clinical care. Upon collection, all biological samples were given unique study identifiers. The principal investigator keeps the de-identification key safe and only a few people can access it. The institutional biobank keeps the rest of the biospecimens according to standard operating procedures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"58"}}